logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
SONN
Sonnet BioTherapeutics Holdings, Inc.
1.26
1 x 1.25
2 x 1.31
bid
ask
+
0.00
0.00%
04:00 PM
Ytd-13.70%
1y-51.72%
1.26
day range
3.23
1.42
52 week range
18.72
Open3.16Prev Close1.26Low1.26High3.23Mkt Cap4.33M
Vol10.43MAvg Vol1.33MEPS-11.35P/EN/AForward P/E-0.10
Beta1.04Short Ratio0.03Inst. Own0.20%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg3.46200-d Avg8.631yr Est160.00

SONN News

Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
globenewswire.com
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Co

Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wednesday, December 3 Und

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
globenewswire.com
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combinatio

PRINCETON, N. J. , Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. , (NASDAQ

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
globenewswire.com
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting

PRINCETON, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: S

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
globenewswire.com
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study

HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is co
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Sonnet to Present at the MedInvest Biotech & Pharma Conference
globenewswire.com
Sonnet to Present at the MedInvest Biotech & Pharma Conference

PRINCETON, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SO
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarket
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Sonnet Releases Virtual Investor "What This Means" Segment
globenewswire.com
Sonnet Releases Virtual Investor "What This Means" Segment

- Dr. Richard Kenney, Chief Medical Officer of Sonnet, discusses the recently announced expansion of

Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer
globenewswire.com
Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in

Sonnet's lead product, SON-1010 (IL12-F H AB), is being evaluated in combination with atezolizumab (
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN)
globenewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sonnet BioTherapeutics, I

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday?
benzinga.com
Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday?

Sonnet BioTherapeutics Inc. SONN stock surged Monday amid high trading volume following news of a tr

US Stocks Edge Lower; Fastenal Posts Upbeat Earnings
benzinga.com
US Stocks Edge Lower; Fastenal Posts Upbeat Earnings

This stock rockets 260% after $900 million mega crypto deal
finbold.com
This stock rockets 260% after $900 million mega crypto deal

Shares of Sonnet BioTherapeutics (NASDAQ: SONN) soared in pre-market trading on Monday after the com
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

SONN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sonnet BioTherapeutics, Inc. Is Fair to Shareholders
businesswire.com
SONN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sonnet BioTherapeutics, In

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy
globenewswire.com
Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurr

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its t
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

US Stocks Likely To Open Lower After A Week Of Records: Tesla In Focus As Elon Musk Announces America Party
benzinga.com
US Stocks Likely To Open Lower After A Week Of Records: Tesla In Focus As Elon Musk Announces Americ

U.S. stock futures declined on Monday after scaling fresh records in the previous truncated week. Fu

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket

Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates
benzinga.com
Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why Datadog Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Datadog Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Box Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Box Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit
globenewswire.com
Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug

PRINCETON, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Sonnet Releases Virtual Investor "What This Means" Segment
globenewswire.com
Sonnet Releases Virtual Investor "What This Means" Segment

- Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonne

Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose
globenewswire.com
Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatmen

Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezoliz

Sonnet Announces Release of Corporate Update Video
globenewswire.com
Sonnet Announces Release of Corporate Update Video

PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SO

Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.
globenewswire.com
Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.

PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SO

Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas
globenewswire.com
Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Tr

SON-1010 is being studied as a combination therapy with trabectedin (Yondelis ® ), the first FDA-app

Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein
globenewswire.com
Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter o

Company advancing development of its modified version of Interleukin-18 (IL-18 Binding Protein Resis

Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
globenewswire.com
Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand

On-demand video webcast now available here
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premar